Also known as: Nicotinamide Mononucleotide, β-NMN
NMN is a direct precursor to NAD+, a coenzyme central to energy metabolism, DNA repair, and sirtuin activation. NAD+ levels decline with age, and NMN supplementation aims to restore them to support cellular resilience and healthspan.
Take in the morning — NAD+ follows a circadian rhythm peaking during the day. Food does not appear to significantly affect absorption.
Oral NMN is absorbed and rapidly converted to NAD+ in tissues. Sublingual use is popular but not proven superior in head-to-head trials.
Daily
Morning, with or without food
Daily
Doses used in recent human trials
Quercetin inhibits CD38, an enzyme that degrades NAD+, potentially extending NMN's effect.
Glutathione and NAD+ are the two main cellular redox systems — support both for resilience.
Complementary mitochondrial support — NAD+ for oxidative metabolism, CoQ10 for electron transport.
Works alongside NAD+-dependent enzymes in mitochondrial energy metabolism.
Read research on NMN
Opens a PubMed search in a new tab